{
  "question_stem": {
    "en": "A 40-year-old man with end-stage renal disease due to type 1 diabetes mellitus is hospitalized for initiation of hemodialysis. A tunneled dialysis catheter is inserted into the right internal jugular vein. Before he is able to undergo dialysis treatment, the patient develops bleeding around the catheter exit site that is difficult to control. He has not been treated recently with anticoagulants. Further evaluation of this patient would most likely show which of the following laboratory abnormalities?",
    "zh": "一名 40 岁男性，因 1 型糖尿病导致终末期肾病（ESRD）入院，准备开始血液透析。 医生将隧道式透析导管插入右侧颈内静脉。 在他接受透析治疗之前，患者在导管出口周围出现难以控制的出血。 患者近期未使用抗凝剂。 对该患者的进一步评估最有可能显示以下哪种实验室异常？"
  },
  "question": {
    "en": "Further evaluation of this patient would most likely show which of the following laboratory abnormalities?",
    "zh": "对该患者的进一步评估最有可能显示以下哪种实验室异常？"
  },
  "options": {
    "A": {
      "en": "Normal\nNormal\nNormal\nProlonged",
      "zh": "正常\n正常\n正常\n延长"
    },
    "B": {
      "en": "Normal\nProlonged\nNormal\nProlonged",
      "zh": "正常\n延长\n正常\n延长"
    },
    "C": {
      "en": "Normal\nProlonged\nNormal\nNormal",
      "zh": "正常\n延长\n正常\n正常"
    },
    "D": {
      "en": "Prolonged\nProlonged\nDecreased\nProlonged",
      "zh": "延长\n延长\n降低\n延长"
    },
    "E": {
      "en": "Prolonged\nProlonged\nNormal\nNormal",
      "zh": "延长\n延长\n正常\n正常"
    }
  },
  "correct_answer": "A",
  "explanation": {
    "en": "Excessive bleeding is common in patients with significant renal dysfunction due in part to the accumulation of UREMIC TOXINS in the circulation. These toxins impair platelet aggregation and adhesion, resulting in a QUALITATIVE platelet disorder characterized by PROLONGED BLEEDING TIME with normal platelet count, prothrombin time (PT), and activated partial thromboplastin time (aPTT). Uremic bleeding can be improved with DIALYSIS as it removes the toxins and partially reverses the bleeding abnormality.\n\n(Choice B) von Willebrand factor (vWF) acts as a bridge between glycoprotein 1b receptors and subendothelial collagen, allowing platelets to bind to damaged vessels. vWF deficiency results in platelet dysfunction with a prolonged bleeding time and normal platelet count. Since vWF also protects factor VIII from degradation, vWF deficiency can result in decreased factor VIII and prolonged aPTT.\n\n(Choice C) Isolated aPTT prolongation is seen with hemophilia A, an X-linked disorder caused by factor VIII deficiency. Heparin use also prolongs the aPTT via antithrombin-associated inhibition of factors II and X (PT is usually normal due to the addition of heparin neutralizers in the PT reagent).\n\n(Choice D) Disseminated intravascular coagulation is a consumptive coagulopathy associated with decreased platelet count and increased bleeding time, aPTT, and PT.\n\n(Choice E) Warfarin inhibits vitamin K-dependent clotting factors (II, VII, IX, and X). Warfarin prolongs both PT and aPTT, but PT is increased much more than aPTT. Platelet count and bleeding time are normal.",
    "zh": "在肾功能严重不全的患者中，过度出血很常见，部分原因是循环中尿毒症毒素的积聚。 这些毒素会损害血小板聚集和粘附，导致血小板功能障碍，其特征是凝血时间延长，血小板计数、凝血酶原时间 (PT) 和活化部分凝血活酶时间 (aPTT) 正常。 尿毒症性出血可以通过透析改善，因为它会清除毒素并部分逆转出血异常。\n\n(选项 B) von Willebrand 因子 (vWF) 充当糖蛋白 1b 受体和内皮下胶原蛋白之间的桥梁，使血小板能够与受损血管结合。 vWF 缺乏导致血小板功能障碍，凝血时间延长，血小板计数正常。 由于 vWF 还可以保护因子 VIII 免受降解，因此 vWF 缺乏会导致因子 VIII 降低和 aPTT 延长。\n\n(选项 C) 在 A 型血友病（一种由因子 VIII 缺乏引起的 X 连锁疾病）中可见孤立的 aPTT 延长。 使用肝素也会通过抗凝血酶相关的对因子 II 和 X 的抑制作用延长 aPTT（由于在 PT 试剂中添加了肝素中和剂，PT 通常是正常的）。\n\n(选项 D) 弥漫性血管内凝血是一种消耗性凝血病，与血小板计数降低、凝血时间、aPTT 和 PT 升高相关。\n\n(选项 E) 华法林抑制维生素 K 依赖性凝血因子（II、VII、IX 和 X）。 华法林延长 PT 和 aPTT，但 PT 的增加比 aPTT 多得多。 血小板计数和凝血时间是正常的。"
  },
  "summary": {
    "en": "This question tests knowledge of the coagulopathy associated with end-stage renal disease (ESRD), specifically uremic platelet dysfunction. It requires understanding the impact of uremic toxins on platelet function and the resulting laboratory findings.\n\nThe best approach is to recall that uremic toxins impair platelet aggregation and adhesion, leading to a qualitative platelet disorder. This results in a prolonged bleeding time with normal platelet count, PT, and aPTT. Consider and eliminate other coagulopathies based on their distinct lab profiles.",
    "zh": "此题考察对终末期肾病 (ESRD) 相关凝血病的了解，特别是尿毒症性血小板功能障碍。 它要求理解尿毒症毒素对血小板功能的影响以及由此产生的实验室结果。\n\n最好的方法是回忆尿毒症毒素会损害血小板聚集和粘附，从而导致血小板功能障碍。 这会导致凝血时间延长，血小板计数、PT 和 aPTT 正常。 根据其他凝血病的不同实验室特征，考虑并排除它们。"
  },
  "tags": "End-stage renal disease; Uremic platelet dysfunction; Bleeding time; Coagulopathy; Platelet aggregation; Dialysis; Internal medicine; Nephrology",
  "category": "Blood",
  "question_id": "1293",
  "has_exhibits": false,
  "exhibit_count": 0,
  "exhibit_files": [],
  "folder_path": "C:\\Datas\\usmle\\step1\\clip\\Blood 23\\1293",
  "extracted_at": "2025-11-05T11:22:08.060016",
  "extraction_config": {
    "temperature": 0.1,
    "top_k": 1,
    "prompt_strategy": "standard"
  },
  "translated_at": "2025-11-07T16:26:36.304017",
  "translation_model": "gemini-2.0-flash-lite",
  "embedding_model": "models/embedding-001",
  "embedding_dimension": 768
}